Medical News

RSS

Lack of reimbursements limit drug-eluting stent market across Latin America

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, despite the rising popularity of drug-eluting stents (DES) across Latin America, bare-metal stents (BMS) will continue to represent a significant portion of the overall coronary stent market through 2014. This trend is especially evident in Brazil, where the public healthcare system does not provide any reimbursement for DES procedures.

30 Jun 2010

Counseling programs increase mammography compliance among low-income women

Even with health insurance, low-income women had lower rates of mammography screening than middle-class women, but a counseling program increased the likelihood of screening.

30 Jun 2010

Sirnaomics receives NIH SBIR grants to advance siRNA therapeutics for critical human diseases

Sirnaomics, Inc. announced today that the company has received two SBIR (Small Business Innovation Research) grants from National Cancer Institute (NCI) and National Institute of Allergy and Infectious Diseases (NIAID), of National Institute of Health (NIH). Sirnaomics, Inc., a biopharmaceutical company founded in early 2007, is dedicated to developing RNA interference (RNAi) therapeutics for treatment of critical human diseases.

30 Jun 2010

Daily Nation reports on USAID's 2-year, $11.5M market linkages initiative to improve food security in East Africa

USAID will contribute $11.5 million for the Market Linkages Initiative (MLI), a two-year program aimed at promoting trade in "staple foods" in East Africa, the Daily Nation reports.

30 Jun 2010

Amylin presents improved indices of beta-cell function after three years of BYETTA(R) therapy

Amylin Pharmaceuticals, Inc. and Eli Lilly and Company today announced results from a study comparing the effect of long-term treatment with either BYETTA® (exenatide) injection or Lantus® (insulin glargine) on overall beta-cell function. (Beta cells are cells in the pancreas that produce insulin.) Three years of BYETTA therapy improved indices of beta-cell function assessed four weeks after discontinuing therapy. These findings were presented at the 70th Annual Scientific Sessions of the American Diabetes Association (ADA) in Orlando, Fla.

30 Jun 2010

When it comes to decision making, older adults fare as well as juniors

Many people believe that getting older means losing a mental edge, leading to poor decision-making. But a new study from North Carolina State University shows that when it comes to making intuitive decisions - using your "gut instincts" - older adults fare as well as their juniors.

30 Jun 2010

Ph II data of perifosine + capecitabine in metastatic CRC to be presented at gastrointestinal cancer congress

Keryx Biopharmaceuticals, Inc. today announced that abstract O-0017, entitled "Subset Analysis of 5-FU Refractory Patients from a Randomized Ph II Study of Perifosine + Capecitabine (P-CAP) vs. Placebo + Capecitabine (CAP) in Patients with 2nd or 3rd Line Metastatic CRC" has been selected for oral presentation at the upcoming 12th World Congress on Gastrointestinal Cancer, to be held in Barcelona, Spain from June 30 - July 2, 2010.

30 Jun 2010

Qigong and Tai Chi offer physical and mental health benefits

An across-the-board review of the health effects of Qigong and Tai Chi finds these practices offer many physical and mental health advantages with benefits for the heart, immune system and overall quality of life.

30 Jun 2010

Cal/OSHA explores ways to strengthen adult film worker safety regulations

California's of Department Occupational Safety and Health (Cal/OSHA) convened its first meeting of an Advisory Panel to explore strengthening adult film worker safety regulations in California today in downtown Los Angeles. In March, the Cal/OSHA Standards Board voted unanimously to convene the Advisory Panel in order to take public comment from health advocates, industry officials and the general public on whether—and how—to amend state health statutes to better protect adult film workers.

30 Jun 2010

AccuVein's AV300 vein illumination device installed in majority of U.S. hospitals

AccuVein announced today that its groundbreaking AV300 vein illumination device has been installed in more than 275 hospitals throughout the United States, less than 12 months after the product began shipping.

30 Jun 2010

States struggle as Congress fails to come through with extra Medicaid money

Congress' rejection - at least for now - of a package extending $16 billion in Medicaid funding and $35.5 billion in other jobless benefits has left at least 30 states struggling to balance next fiscal year's budgets with tax increases, spending cuts and layoffs, The Associated Press reports. The new fiscal year begins in just days for most states.

30 Jun 2010

New hope for patients with drug-resistant depression

New research shows that a unique strain of laboratory mice characterized at Penn State University has behavioral, hormonal, and neurochemical characteristics that are similar to those of human patients with drug-resistant forms of depression.

30 Jun 2010

Herniated disk can cause low back and leg pain in adults

A literature review, led by Dr. Joseph Lee, published in the June 2010 issue of the Journal of the American Academy of Orthopaedic Surgeons (JAAOS) suggests that a herniated disk is one of the most frequent causes of low back and leg pain in adults, but surgery is not for everyone. Between 60 and 80 percent of people will experience low back pain at some point in their lives.

30 Jun 2010

Groton Biosystems releases in-situ filter sampling probe for automated, manual extraction of cell-free samples

Groton Biosystems, the leader in automated online bioprocess sampling, has announced the release of a sterilizable, disposable in-situ filter sampling probe for automated and manual extraction of cell-free samples. The rugged design of this product delivers extended service life in typical bioreactor applications and features a nonbinding inert surface which resists clogging throughout the extended process runtimes most often associated with cell culture and perfusion applications.

30 Jun 2010

Asbestos induces cell necrosis, promotes tumor growth

More than 20 million people in the U.S., and many more worldwide, who have been exposed to asbestos are at risk of developing mesothelioma, a malignant cancer of the membranes that cover the lungs and abdomen that is resistant to current therapies.

30 Jun 2010

FDA grants approval for first generic version of Effexor XR antidepressant capsules

On June 28, the U.S. Food and Drug Administration approved the first generic version of Effexor XR capsules (venlafaxine hydrochloride) to treat major depressive disorder.

30 Jun 2010

Preliminary findings show RA drug reduces brain damage in stroke patients

A drug used to treat rheumatoid arthritis also reduces the damage a stroke inflicts on the brain according to lab research and preliminary findings from a clinical trial of stroke patients. The results open the door for a larger clinical study to refine the drug anakinra's use as an effective therapy for victims of stroke.

From The University of Manchester 30 Jun 2010

Geriatric population soars while NIH devotes modest resources to aging research

With a nudge from the new health care law and pressure from Medicare, hospitals, doctors and nurses are struggling to prepare for explosive growth in the numbers of high-risk elderly patients. More than 40 percent of adult patients in acute care hospital beds are 65 or older. Seventy million Americans will have turned 65 by 2030.

30 Jun 2010

Erye's new facility passes SFDA inspection for manufacture of penicillin, cephalosporin powder

NeoStem, Inc., an international biopharmaceutical company with operations in the U.S. and China, announced on June 15, 2010 that its 51% owned Suzhou Erye pharmaceutical subsidiary passed the government inspection by the State Food and Drug Administration ("SFDA") in China to manufacture penicillin and cephalosporin powder for injection at its new manufacturing facility.

30 Jun 2010

Oil spill disaster raises concern in the Gulf region

Two months after the Deepwater Horizon oil rig explosion caused the oil spill now globally acknowledged as the worst environmental disaster in our nation's history, the residents of the Gulf region immediately impacted are exhibiting dramatically high levels of anxiety, both among adults and children, about the future health and well-being of the region. Many children – and parents – still recovering from Katrina are now reeling from a second major trauma as a result of the oil catastrophe.

30 Jun 2010

Medical News

Lack of reimbursements limit drug-eluting stent market across Latin America

Counseling programs increase mammography compliance among low-income women

Sirnaomics receives NIH SBIR grants to advance siRNA therapeutics for critical human diseases

Daily Nation reports on USAID's 2-year, $11.5M market linkages initiative to improve food security in East Africa

Amylin presents improved indices of beta-cell function after three years of BYETTA(R) therapy

When it comes to decision making, older adults fare as well as juniors

Ph II data of perifosine + capecitabine in metastatic CRC to be presented at gastrointestinal cancer congress

Qigong and Tai Chi offer physical and mental health benefits

Cal/OSHA explores ways to strengthen adult film worker safety regulations

AccuVein's AV300 vein illumination device installed in majority of U.S. hospitals

States struggle as Congress fails to come through with extra Medicaid money

New hope for patients with drug-resistant depression

Herniated disk can cause low back and leg pain in adults

Groton Biosystems releases in-situ filter sampling probe for automated, manual extraction of cell-free samples

Asbestos induces cell necrosis, promotes tumor growth

FDA grants approval for first generic version of Effexor XR antidepressant capsules

Preliminary findings show RA drug reduces brain damage in stroke patients

Geriatric population soars while NIH devotes modest resources to aging research

Erye's new facility passes SFDA inspection for manufacture of penicillin, cephalosporin powder

Oil spill disaster raises concern in the Gulf region

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News